In breast cancer, high IL-30 expression levels by tumor and draining lymph node infiltrating monocytes, macrophages, and CD33+/CD11b+ myeloid cells correlated with triple-negative and HER2+ molecular types, advanced stage, recurrence, and reduced overall survival. Here, IL27 is linked to breast carcinoma.